About this trial
The goal of this RCT is to compare efficacy between mirogabalin and pregabalin in pain reducing after unilateral primary total knee arthroplasty.
The main question\[s\] it aims to answer are:
• Does mirogabalin have better pain reduction than pregabalin after unilateral primary total knee arthroplasty.
Participants will randomized to mirogabalin or pregabalin group and will take the drug for 2 weeks after TKA. Researchers will compare to pregabalin group to see pain and functional outcomes after TKA.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 50-85 years old
Unilateral primary osteoarthritis undergoing primary TKA
ASA I-III
Disqualifiers
GFR <60
Allergy to drug in this study
Cannot underwent spinal anesthesia and adductor canal block
Taking gabapentinoid within 3 months before surgery
Trial design
Parallel
Treatments tested in this trial
Mirogabalin
DrugParticipants will receive 5 mg of mirogabalin, twice a day, after breakfast and dinner, for 2 weeks.
Pregabalin
DrugParticipants will receive 75 mg of pregabalin, once a day before bedtime, for 2 weeks.
Treatment groups
Trial outcomes
Primary outcomes
Pain score
Visual analog scale at rest and motion (0-100 points, 0 mean best, 100 mean worst)
Secondary outcomes
Morphine consumption
Total morphine consumption in hospital (mg)
Range of motion
Using long arm goniometer (degrees)
Knee society score
report in point (0-100, 0 mean worst, 100 mean best)
Knee injury and Osteoarthritis Outcome Score (KOOS)
report in point (0-100, 0 mean worst, 100 mean best)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.